Show simple item record

dc.contributor.authorLYNCH, MARINA ANNETTA
dc.date.accessioned2013-08-07T11:03:15Z
dc.date.available2013-08-07T11:03:15Z
dc.date.issued2012
dc.date.submitted2012en
dc.identifier.citationO'Reilly JA, Lynch M, Rosiglitazone improves spatial memory and decreases insoluble A?(1-42) in APP/PS1 mice., Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology, 7, 1, 2012, 140-4en
dc.identifier.otherY
dc.identifier.urihttp://hdl.handle.net/2262/66884
dc.descriptionPUBLISHEDen
dc.description.abstractIdentifying potential novel treatments for patients with Alzheimer?s disease (AD) is a major challenge and drugs used for other indications, particularly if they have anti- inflammatory properties, are particularly attractive. The nuclear receptor peroxisome proliferator-activated receptor-! (PPAR!) is a ligand-activated transcription factor.en
dc.description.sponsorshipThe Health Research Board, Irelanden
dc.format.extent140-4en
dc.language.isoenen
dc.relation.ispartofseriesJournal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology;
dc.relation.ispartofseries7;
dc.relation.ispartofseries1;
dc.rightsYen
dc.subjectAlzheimer?s diseaseen
dc.subject.lcshAlzheimer?s diseaseen
dc.titleRosiglitazone improves spatial memory and decreases insoluble A?(1-42) in APP/PS1 mice.en
dc.typeJournal Articleen
dc.type.supercollectionscholarly_publicationsen
dc.type.supercollectionrefereed_publicationsen
dc.identifier.peoplefinderurlhttp://people.tcd.ie/lynchma
dc.identifier.rssinternalid83609


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record